diazooxonorleucine has been researched along with Experimental Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, M; Ardalan, B; Cooney, DA; Jayaram, H; Villacorte, D | 1 |
| Burchenal, JH | 1 |
| Catane, R; Houchens, DP; Muggia, FM; Ovejera, AA; Sheridan, MA | 1 |
3 other study(ies) available for diazooxonorleucine and Experimental Leukemia
| Article | Year |
|---|---|
Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
Topics: Adenocarcinoma; Animals; Azaserine; Colonic Neoplasms; Diazooxonorleucine; Glutamine; Intestine, Small; Isoxazoles; Leukemia P388; Leukemia, Experimental; Mice; Neoplasms, Experimental; Pentosephosphates; Phosphoribosyl Pyrophosphate | 1982 |
Antitumor effects of azaserine and DON.
Topics: Animals; Antineoplastic Agents; Azaserine; Azo Compounds; Diazooxonorleucine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leukemia, Experimental; Mice; Neoplasms | 1979 |
Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
Topics: Animals; Azo Compounds; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation, Preclinical; Female; Humans; Leukemia, Experimental; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous | 1979 |